ARCHIVES

Study Finds High-Risk Women Reluctant To Take Tamoxifen

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Medicare Coverage For Clinical Trials Tops NBCC Agenda

January 30, 1998

In Brief: Panel Meeting Canceled; New Senior Executive Service Draws Enthusiastic Response At NCI

July 13, 1979

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989